Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

BUY
$0.14 - $0.23 $8,820 - $14,490
63,000 Added 233.33%
90,000 $16,000
Q1 2022

May 13, 2022

BUY
$0.22 - $0.47 $5,940 - $12,690
27,000 New
27,000 $6,000
Q4 2021

Feb 14, 2022

SELL
$0.41 - $0.91 $12,300 - $27,300
-30,000 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$1.24 - $3.3 $37,200 - $99,000
30,000 New
30,000 $38,000

About SOLENO THERAPEUTICS INC


  • Ticker SLNO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 8,101,250
  • Market Cap $468M
  • Description
  • Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...
More about SLNO
Track This Portfolio

Track Warberg Asset Management LLC Portfolio

Follow Warberg Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Warberg Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Warberg Asset Management LLC with notifications on news.